Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Plant-based diets linked to lower dementia risk for vulnerable heart patients
Adults with a history of CVD, type 2 diabetes and stroke were all associated with a lower dementia risk if they ate a whole food, plant-based diet. The study, published in JACC: Advances, was based on data from more than 71,000 U.K. Biobank participants.
Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health
The popularity of various obesity management medications has increased significantly in recent years. According to a new analysis of more than 60,000 patients, some of these drugs are associated with more cardiovascular benefits than others.
The universal screening of children for familial hypercholesterolemia can save lives
If familial hypercholesterolemia is not detected and treated early, it can lead to premature heart attacks and heart disease in young patients.
ACC calls for more screening in new scientific statement on inflammation
The document provides an in-depth look at the close relationship between inflammation and cardiovascular disease. "The time for taking action has now arrived," the authors wrote.
Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients
Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

doctor fruits vegetables vegetarian diet

Plant-based diets linked to lower dementia risk for vulnerable heart patients

Adults with a history of CVD, type 2 diabetes and stroke were all associated with a lower dementia risk if they ate a whole food, plant-based diet. The study, published in JACC: Advances, was based on data from more than 71,000 U.K. Biobank participants.

obesity semaglutide tirzepatide GLP-1 drugs weight loss

Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health

The popularity of various obesity management medications has increased significantly in recent years. According to a new analysis of more than 60,000 patients, some of these drugs are associated with more cardiovascular benefits than others.

The universal screening of children for familial hypercholesterolemia can save lives

If familial hypercholesterolemia is not detected and treated early, it can lead to premature heart attacks and heart disease in young patients.

A new ACC consensus document of coronary inflammation calls for wider use of hs-CRP testing to identify more patients with residual heart attack risk, even if they are optimal statin therapy.

ACC calls for more screening in new scientific statement on inflammation

The document provides an in-depth look at the close relationship between inflammation and cardiovascular disease. "The time for taking action has now arrived," the authors wrote.

Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

FDA approves treatment of rare genetic disorder in children as young as 1 year old

Evinacumab-dgnb, sold by Regeneron under the brand name Evkeeza, can now be used to treat homozygous familial hypercholesterolemia in much younger patients.

AI delivers helpful heart health advice—but not every time

AI-powered chatbots can be valuable resources when users have questions about cardiovascular health—but they are still far from perfect.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

CVD responsible for 1 in 3 deaths around the world

Cardiovascular disease remains the world’s leading cause of death, according to a special report from the American College of Cardiology. The new analysis, described by one cardiologist as a "wake-up call," includes data from more than 200 countries and territories.